Browsing Tag
Merus
2 posts
Why Merus is the hottest takeover target in oncology right now—Genmab said to be frontrunner
Genmab is reportedly close to acquiring Merus in a high-stakes biotech deal that could reshape the oncology sector. Read the full breakdown now.
U.S. stocks top losers: Asana, Chart Industries, and Dollar Tree drop sharply amid earnings concerns
Explore why Asana, Chart Industries, Dollar Tree, and other top U.S. stocks plunged on June 4, 2025, with detailed analysis and investor insights.